HIS
RETA

Harvest Investment Services’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Harvest Investment Services’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-18,655
Closed -$1.9M – 211
2023
Q2 		$1.9M Buy
18,655
+8,358
+81% +$791K 1.08% 26
2023
Q1 		$936K Buy
+10,297
New +$604K 0.72% 47

Other funds holding RETA

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Harvest Investment Services's RETA Position: Q3 2023 in Review

Harvest Investment Services sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q3 2023, closing a stake of 18,655 shares — an estimated $1.9M sold.

Harvest Investment Services first reported a position in RETA in Q1 2023 and held it in 2 quarters. The position peaked at $1.9M in Q2 2023. 2 funds tracked by Wall St. Rank hold RETA as of Q3 2023.

  • Harvest Investment Services reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Harvest Investment Services sold 18,655 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q3 2023, an estimated $1.9M.
  • Harvest Investment Services first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q1 2023 and held it in 2 quarters.
  • Harvest Investment Services's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $1.9M in Q2 2023.
  • 2 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q3 2023.

Based on Harvest Investment Services's 13F filing for Q3 2023, filed 14 Nov 2023.